e-learning
resources
Berlin 2008
Monday, 06.10.2008
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease
P. Tabarsi, A. Tehrani, P. Baghaei, D. Mansouri, F. L. Altice (Tehran, Islamic Republic Of Iran; New Haven, United States Of America)
Source:
Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session:
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2547
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Tabarsi, A. Tehrani, P. Baghaei, D. Mansouri, F. L. Altice (Tehran, Islamic Republic Of Iran; New Haven, United States Of America). Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease. Eur Respir J 2008; 32: Suppl. 52, 2547
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Lymphopenia as a mortality predictor in non HIV pulmonary TB patients
Source: Eur Respir J 2004; 24: Suppl. 48, 424s
Year: 2004
Treatment outcomes under early correction of chemotherapy in adolescents with advanced pulmonary TB
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Predictors of death in patients with MDR-TB and HIV
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection
Source: ISSN=ISSN 1810-6838, ISBN=, page=190
Year: 2006
Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy
Source: Eur Respir J 2009; 34: 277-278
Year: 2009
Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
A choice of regimen improves completion for patients with latent TB infection
Source: Breathe 2008; 4: 366
Year: 2008
Initial treatment and mortality in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
Economic impact of delayed multiple-inhaler triple therapy initiation in COPD patients
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Quality of sleep and psychiatric parameters in patients with HIV infection on highly active antiretroviral therapy (HAART)
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Mortality causes in patients with advanced lung disease in long term oxygen therapy
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Timing of concurrent highly active antiretroviral therapy (HAART) in adults with tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 302s
Year: 2006
Long-term outcomes of directly observed therapy in a low tuberculosis incidence setting
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Early rehabilitation is associated with reduced in-hospital mortality from sepsis in patients with sarcopenia
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Statin therapy and reduced risk of pneumonia in elderly patients with diabetes
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept